Renal Cell Carcinoma

Filter By:
04:28
In this segment, panelists discuss the impact of prior radiotherapy and non-clear cell histology on treatment selection for patients with renal cell carcinoma. To view more from this discussion, visit http://www.o...
by:onclivetv | 76 views
28:46
This series of interviews with eight expert faculty is filmed on location during the 2014 American Society of Clinical Oncology (ASCO) Annual meeting, where the most current cancer data is presented and examined. Following the scientific sessions, Dr. James Epstein reviews and explores some of the most significant research findings in multiple tumo...
by:imedex | 350 views
05:16
Held annually in South Florida every January, The Symposium on Clinical Interventional Oncology (CIO) features a concentrated 2-day program renowned for its originality, patient-care focus and dynamic learning format. CIO focuses on highlighting the most viable and sought-after treatments in interventional oncology while shining a spotlight on cur...
by:InterventionalOncology | 250 views
02:37
SAN FRANCISCO—The ability of cancer cells to evolve clonally into molecularly distinct strands needs to be considered when selecting targeted therapies to treat renal cancer, according to Dr Tom Powles MBBS, MRCP, MD speaking at the ASCO GU Cancers Symposium here. Dr Tomasz Beer, MD FACP from Orego...
by:AudioMedica | 761 views
01:52
For more updates visit www.oncology.... Dr. Viktor Grünwald with an update on ECC 2013 Abstract #2702. Tumor response is an independent prognostic factor in patients (pts) treated for metastatic renal cell carcinoma (mRCC).
by:oncologyeducation | 3624 views
20:34
Download from iTunes: https://itun... Several cancer types can spread to the brain including lung, breast, melanoma, renal cell carcinoma and gastrointestina​l tract cancers such as colon and rectal. Secondary brain cancer (cancer that has metastasized to the brain) is more pr...
by:mdanderson | 2418 views
06:09
Dr. William Grady, medical director of the gastrointestina​l cancer program at Seattle Cancer Care Alliance, helps us understand Lynch syndrome, a genetic condition connected to a multitude of cancers, including brain cancer, ovarian cancer, kidney cancer, skin cancer and, predominately, colon cancer. Dr. Grady talks about microsatellite instability...
by:patientpower | 1505 views
10:00
A wave in research of metastatic melanoma has raised the question: Can drugs for some cancers be used to understand responses in other cancers? The answer is yes, but research is ongoing. Dr. Brian Koffman, a doctor turned patient, and Dr. Jeffrey Sosman, from Vanderbilt-Ingr​am Cancer Center, discus...
by:patientpower | 3136 views
01:27
http://cance... Dr. Sumanta (Monty) Pal, medical oncologist at City of Hope Cancer Center in Duarte, CA, describes the main types of kidney cancer and discusses the differences in their management.
by:cancergrace | 1468 views
02:40
http://cance... Dr. Sumanta (Monty) Pal, medical oncologist at City of Hope Cancer Center in Duarte, CA, explains the range of options and his approach to second line treatment of kidney cancer.
by:cancergrace | 1885 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)